Loading your page…
Psychedelic (Lysergic acid diethylamide)
We often think of LSD as a purely recreational 'trip,' but chemically, it's a fascinating serotonergic compound that dances elegantly with our brain's receptors. Despite its reputation, LSD is more than just a psychedelic; it's a molecule that challenges our understanding of consciousness by acting as a potent agonist at the 5-HT2A receptor, among others. This interaction doesn't just 'flip a switch'—it orchestrates a symphony of neural activity that alters perception and cognition in profound ways.
At the molecular level, LSD (Lysergic acid diethylamide) exhibits a high affinity for the 5-HT2A receptor, where it acts as a partial agonist, but its influence extends to several other sites, including 5-HT1A, 5-HT2C, and dopamine D2 receptors. This multi-receptor engagement creates a complex signaling cascade, akin to a dimmer switch modulating neural circuits rather than simply turning them on or off [1]. Pharmacokinetically, LSD is absorbed rapidly, reaching peak plasma concentrations in approximately 1.5 to 2 hours, with a half-life of around 3 to 5 hours [2]. It undergoes hepatic metabolism primarily via CYP450 enzymes, producing inactive metabolites excreted in urine [3].
In reality, LSD is not approved for any medical indications, but it continues to intrigue researchers exploring its potential in treating anxiety, depression, and PTSD. The safety profile requires careful consideration; while LSD is not associated with dependence, it can provoke acute psychological distress, particularly in individuals with pre-existing mental health conditions [4]. No black box warnings exist, but notable adverse effects include hallucinations, paranoia, and, in rare cases, persistent psychosis. LSD's legal status varies globally, yet it remains a Schedule I substance in the U.S., reflecting its high abuse potential and lack of accepted medical use. This status complicates research, though ongoing studies aim to unravel its therapeutic promise.
Authorized research personnel may request deployment of this compound for laboratory analysis.
Live dossier
FGPsychedelic (Lysergic acid diethylamide)
LSD is a Psychedelic compound currently under research investigation.
Research compound - safety data limited. For institutional research only
Citations
AI output is informational only. Verify via regulatory channels before operational deployment.
Share your experience anonymously - no account needed
Your identity is completely anonymous. Help others by sharing dosage, effects, duration, and side effects. This data helps researchers improve treatments.